Opana | Pain Management Near me

Opana is a strong prescription opioid used to treat severe pain, but due to its potential for abuse and addiction, it is classified as a Schedule II controlled substance and we are here as Pain Management Near Me to sell for everyone in pains caused by accident or sickness.

When discussing Opana in online content, it is important to provide accurate and informative details about its uses, side effects, risks, and potential alternatives, while also avoiding any promotional or misleading language. Pain Management Near Me

Opana, also known by its generic name oxymorphone, is a powerful opioid medication primarily used to manage severe pain that requires around-the-clock treatment. It belongs to the class of drugs known as narcotic analgesics and works by acting on certain receptors in the brain to reduce pain signals.

Opana is available in various formulations, including immediate-release and extended-release forms. However, due to its high potential for misuse, abuse, and addiction, it is classified as a Schedule II controlled substance in the United States. Common side effects of Opana may include dizziness, drowsiness, constipation, nausea, vomiting, and headache.

It is essential to use Opana exactly as prescribed by a healthcare professional and to be aware of the risks associated with its use. Regular monitoring and open communication with a healthcare provider are crucial when taking Opana to ensure its safe and effective use in managing pain.

We are selling the 5mg online, the ER, the extended-release form of oxymorphone, this 5mg Extended Release Tablets for Sale Online is for around-the-clock treatment of pain and should not be used on an as-needed basis for pain.

Warnings 

You should not use this medication if you have severe asthma or breathing problems, a blockage in your stomach or intestines, or moderate to severe liver disease.

Oxymorphone can slow or stop your breathing, and may be habit-forming. MISUSE OF OPANA CAN CAUSE ADDICTION, OVERDOSE, OR DEATH, especially in a child or other person using the medicine without a prescription.

Taking this MED during pregnancy may cause life-threatening withdrawal symptoms in the newborn.

Fatal side effects can occur if you use this tablets with alcohol, or with other drugs that cause drowsiness or slow your breathing.

Before taking this medicine for Pain Management Near Me

You should not take this med if you are allergic to oxymorphone, or if you have:

• severe asthma or breathing problems;
• severe liver disease; or
• a stomach or bowel obstruction (including paralytic ileus).

To make sure it is safe for you, tell your doctor if you have ever had:

• breathing problems, sleep apnea (breathing that stops during sleep);
• a head injury or seizures;
• drug or alcohol addiction, or mental illness;
• urination problems;
• liver or kidney problems; or
• problems with your gallbladder, pancreas, or thyroid.

If you use the medication while you are pregnant, your baby could become dependent on the drug. This can cause life-threatening withdrawal symptoms in the baby after it is born. Babies born dependent on opioids may need medical treatment for several weeks.

severe drowsiness or slow breathing in the nursing baby.

How should I Use This MED?

Take exactly as prescribed by your doctor. Follow the directions on your prescription label and read all medication guides. Never use this pain management pill in larger amounts, or for longer than prescribed. Tell your doctor if you feel an increased urge to take more of this medicine.

Opana pills | opioid  Medication

Opana 5mg online Extended Release Tablets. Never share it with another person, especially someone with a history of drug abuse or addiction. MISUSE CAN CAUSE ADDICTION, OVERDOSE, OR DEATH. Keep the Opana opioid medication in a place where others cannot get to it. Selling or giving away opioid medicine is against the law. Opana Pain Management near me.

Stop using all other around-the-clock opioid pain medications when you start taking the 5mg tablet. Take this MED on an empty stomach, at least 1 hour before or 2 hours after a meal. Take the medicine at the same times each day. Swallow the tablet whole to avoid exposure to a potentially fatal overdose. Do not crush, chew, break, or dissolve. Take only one of its ER extended-release tablet at a time.

To avoid choking, do not lick or wet the tablet before placing it in your mouth. Never crush or break a pill to inhale the powder or mix it into a liquid to inject the drug into your vein. This can cause in death.

Do not stop using this med suddenly after long-term use, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using it.

Store at room temperature away from moisture, heat, and light. Keep track of your medicine. You should be aware if anyone is using it improperly or without a prescription.

Do not keep leftover opioid medication. Just one dose can cause death in someone using this medicine accidentally or improperly. Ask your pharmacist where to locate a drug take-back disposal program. If there is no take-back program, flush the unused medicine down the toilet.

 

Dosing information and Pain Management Near Me

Usual Adult Dose For Pain Management: The following dosing recommendations can only be considered suggested approaches to what is actually a series of clinical decisions over time; each patient should be managed individually.

ORAL:
Use as first Opioid Analgesic:
-Initial dose: 10 to 20 mg orally every 4 to 6 hours as needed for pain
Maximum initial dose: 20 mg

 

Conversion from Other Oral Opioids to Oral Oxymorphone:
-Determine equipotent dose using published potency tables; it is safest to start therapy by administering one-half the calculated total daily oxymorphone requirement in 4 to 6 equally divided oral doses every 4 to 6 hours and gradually adjust dose as needed.

 

Comments:
-Dose conversion should be done carefully and with close monitoring due to large patient variability in regards to opioid analgesic response.
-Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.
-Monitor closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy and with each dose increase. Pain Management Near Me

 

-Due to risks of addiction, abuse, and misuse, even at recommended doses, reserve use for patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products) have not been tolerated, or are not expected to be tolerated, or have not provided adequate analgesia, or are not expected to provide adequate analgesia.

 

Usual Adult Dose of Opana ER for Chronic Pain: Use as the First Opioid Analgesic or for those who are NOT Opioid Tolerant:
Initial dose: Extended-release tablets: 5 mg orally every 12 hours CONVERSION DOSES:
Immediate-Release Oxymorphone to Extended-Release Oxymorphone Tablets: Administer same total daily dose

-Initial dose: One-half total daily immediate-release requirement as extended-release tablet orally every 12 hours

From Other Oral Opioids to Oxymorphone Extended-Release Tablets:
-Discontinue all other around-the-clock opioid drugs when oxymorphone extended-release therapy is initiated.

-Published potency tables can be used to estimate a patient’s 24-hour oral oxymorphone requirement; however, due to substantial inter-patient variability, the conversion should then underestimate a patient’s 24-hour requirement and provide rescue medication as the dose is titrated.

-Alternatively, the following conversion factors (CF) may be used to convert selected oral opioids to the extended-release oxymorphone tablet: Oxymorphone, CF=1; Hydrocodone, CF=0.5; Oxycodone, CF=0.5; Methadone, CF= 0.5, Morphine, CF=0.333

-As an example: Sum the total daily dose of prior oral opioid; multiply that sum by the CF to obtain 24-hour oral oxymorphone requirement; divide by 2 to calculate approximate starting dose to be given every 12 hours, round down, if necessary.

-These CFs cannot be used to convert from oxymorphone extended-release tablets to the selected oral opioid as doing so will result in overestimation of the oral opioid dose and may result in fatal respiratory depression